The duration required to obtain an intravenous immunoglobulin (IVIg) prescription varies significantly based on several factors. This timeframe is not fixed and depends on diagnostic processes, insurance authorization procedures, and the availability of specialist consultations.
The timely acquisition of necessary medications like IVIg is crucial for managing various autoimmune and immunodeficiency conditions. Delayed access can lead to disease progression or exacerbate existing symptoms. Historically, limited awareness and complex approval processes have presented challenges to prompt treatment initiation.
